Baodong Qin
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of the Combination of Anlotinib and JS001 in EGFR-TKI Resistant T790M-Negative NSCLC (NCT04116918) | Baodong Qin | 2019-09-01 |
| Effect of Chemotherapy on PD-L1 in NSCLC (NCT03701607) | Baodong Qin | 2018-09-01 |
| Effect of Chemotherapy on TMB in NSCLC (NCT03683407) | Baodong Qin | 2018-09-01 |
Track Baodong Qin automatically
Every clearance here is in the API, with alerts when new ones post.